Aasen Thomas H

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
15
Insider Sells Sum
$9.8M

Insider Activity of Aasen Thomas H

The largest sale of all time was on 2013-08-13 and amounted to 120000 shares of ACADIA Pharmaceuticals Inc. for $2.42M.

Biography of Aasen Thomas H

No biography is available at this moment.

2014-04-04SaleACADIA Pharmaceuticals Inc.
ACAD
EXEC VP, CFO AND CBO
30,000
0.0319%
$22.48$674,520+24.71%
2014-01-02SaleACADIA Pharmaceuticals Inc.
ACAD
EXEC VP, CFO AND CBO
60,000
0.0638%
$24.88$1.49M-4.87%
2013-10-01SaleACADIA Pharmaceuticals Inc.
ACAD
EXEC VP, CFO AND CBO
60,000
0.064%
$27.87$1.67M-17.92%
2013-08-13SaleACADIA Pharmaceuticals Inc.
ACAD
EXEC VP, CFO AND CBO
120,000
0.1343%
$20.15$2.42M+13.99%
2013-04-11SaleACADIA Pharmaceuticals Inc.
ACAD
EXEC VP, CFO AND CBO
80,000
0.081%
$11.06$884,800+71.53%
2013-04-01SaleACADIA Pharmaceuticals Inc.
ACAD
EXEC VP, CFO AND CBO
80,000
0.0932%
$7.68$614,168+182.78%
2012-11-28SaleACADIA Pharmaceuticals Inc.
ACAD
EXEC VP, CFO AND CBO
18,200
0.0337%
$5.25$95,548+181.32%
2012-11-27SaleACADIA Pharmaceuticals Inc.
ACAD
EXEC VP, CFO AND CBO
61,800
0.1289%
$6.24$385,719+165.01%
2008-02-13SaleACADIA Pharmaceuticals Inc.
ACAD
Vice Pres., CFO, Treas. & Sec.
16,000
0.0431%
$10.84$173,440-72.65%
2007-12-06SaleACADIA Pharmaceuticals Inc.
ACAD
Vice Pres., CFO, Treas. & Sec.
8,000
0.0118%
$6.55$52,420-36.55%
2007-11-14SaleACADIA Pharmaceuticals Inc.
ACAD
Vice Pres., CFO, Treas. & Sec.
16,000
0.0462%
$11.17$178,722-26.57%
2007-08-15SaleACADIA Pharmaceuticals Inc.
ACAD
Vice Pres., CFO, Treas. & Sec.
32,000
0.0893%
$15.65$500,840-31.07%
2006-08-24SaleACADIA Pharmaceuticals Inc.
ACAD
Vice Pres., CFO, Treas. & Sec.
16,000
0.0528%
$8.00$128,000+20.25%
2006-05-18SaleACADIA Pharmaceuticals Inc.
ACAD
Vice Pres., CFO, Treas. & Sec.
16,000
0.058%
$10.67$170,720-18.32%
2006-02-15SaleACADIA Pharmaceuticals Inc.
ACAD
Vice Pres., CFO, Treas. & Sec.
24,000
0.0986%
$15.10$362,400-40.08%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.